Roche Races for Dominance in Obesity Drug Market Amidst Global Health Developments
Published on: Sept. 24, 2025, 2:28 a.m. | Source: Devdiscourse
Roche is advancing its experimental obesity drug to a late-stage trial to join top players like Eli Lilly in the weight-loss market. Meanwhile, Pfizer acquires Metsera to expand in obesity treatments, and other firms like McKesson, J&J, and Celltrion make strategic moves. EU counters Trump's claims linking Tylenol to autism.
